Keyphrases
T Cell Response
100%
Epstein-Barr Virus
100%
Epstein-Barr Virus-positive
100%
CD8+
100%
Virus-specific
100%
CD4+
100%
Nasopharyngeal Carcinoma
100%
EBNA1
100%
Potential Therapeutics
100%
Therapeutic Vaccine
100%
Dual Stimulation
100%
Chimeric Antigen
100%
LMP2
75%
HLA Class II
75%
CD4 T Cells
50%
Memory T Cell Response
50%
Virus Proteins
25%
Latent Membrane Protein 1 (LMP1)
25%
Tumor Cells
25%
Tumor
25%
Epitope
25%
Nuclear Antigens
25%
Virus Strains
25%
Memory CD8+ T Cells
25%
HLA Class I
25%
CD8+ T Cells
25%
Dendritic Cells
25%
Fusion Protein
25%
High Incidence
25%
Memory CD4+ T Cells
25%
CD4+ T Cell Epitope
25%
Immunogenicity
25%
Virus-associated Malignancies
25%
Viral Antigens
25%
Gene Sequencing
25%
Chinese Population
25%
CD8+ T Cell Epitopes
25%
HLA Class I Molecules
25%
Southern China
25%
Recombinant MVA
25%
Modifying Gene
25%
Nuclear Positioning
25%
Modified Vaccinia Virus Ankara
25%
Redirection
25%
Medicine and Dentistry
T-Cell Response
100%
Epstein Barr Virus
100%
Cytotoxic T-Cell
100%
Nasopharynx Carcinoma
100%
Therapeutic Vaccine
100%
Epitope
60%
In Vitro
40%
T-Helper Cell
40%
Memory T Cell
40%
Viral Protein
20%
Tumor Cell
20%
Allele
20%
Carboxy Terminal Sequence
20%
Membrane Protein
20%
Cancer
20%
Cell Nucleus Antigen
20%
Virus Antigen
20%
Dendritic Cell
20%
Vaccinia Virus
20%
Virus Strain
20%
CD8 Antigen
20%
Cancer Incidence
20%
Immunogenicity
20%
Gene Sequence
20%
Chimeric Protein
20%
Virus
20%
Immunology and Microbiology
Epstein Barr Virus
100%
Cytotoxic T-Cell
100%
CD4
100%
Epitope
60%
Memory T Cell
40%
T Cell
20%
Tumor Cell
20%
Viral Protein
20%
Cell Nucleus Antigen
20%
Virus Strain
20%
Carboxy Terminal Sequence
20%
CD8
20%
Allele
20%
T-Helper Cell
20%
Dendritic Cell
20%
Gene Sequence
20%
Immunogenicity
20%
Virus Antigen
20%
Vaccinia Virus
20%
Cancer Incidence
20%
Virus
20%
Pharmacology, Toxicology and Pharmaceutical Science
Epstein-Barr Virus
100%
Nasopharynx Carcinoma
100%
CD8 Antigen
100%
Therapeutic Vaccine
100%
Epitope
60%
Viral Protein
20%
Neoplasm
20%
Chimeric Protein
20%
Cancer Incidence
20%
Membrane Protein
20%
Vaccinia Virus
20%
Cell Nucleus Antigen
20%
Virus Antigen
20%
Virus Strain
20%
Immunogenicity
20%